The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

Currently, the most widely used vaccine against TB is the Bacillus Calmette-Guérin (BCG). Developed in 1921, the vaccine ...

Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...

Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.

This important study reveals that disrupting fatty acid metabolism in macrophages significantly restricts the growth of Mycobacterium tuberculosis, showing that impaired lipid processing triggers ...

Australian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine ...

This study investigates the role of macrophage lipid metabolism in the intracellular growth of Mycobacterium tuberculosis. By using a CRISPR-Cas9 gene-editing approach, the authors knocked out key ...

Every year, 10 million people contract tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb), and approximately 1.5 million patients succumb to the disease. Treatment ...

Feb. 20, 2025 — Biologists have discovered a new type of RNA-splicing regulation that helps to determine which protein-coding exons will be included in messenger RNA ...

In today’s interconnected world, the spread of pathogenic microorganisms poses a significant challenge to global public ...

SEREMBAN: The leprosy situation in the two Orang Asli villages in Kuala Pilah near here is under control, with no necessity to isolate the eight patients, said the Health Ministry.

A simple model projected which strains were likely to be highly transmissible, with implications for public health.